China Resources Medical Holdings Company Limited
HKEX:1515.HK
3.47 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 10,107.5 | 5,620.461 | 4,447.477 | 2,750.65 | 2,115.32 | 2,059.478 | 1,877.724 | 1,532.831 | 1,372.267 | 1,206.265 | 887.354 | 758.032 |
| Cost of Revenue
| 8,201.663 | 4,649.321 | 3,513.922 | 2,114.143 | 1,353.029 | 1,302.8 | 1,209.487 | 1,126.198 | 1,042.686 | 908.562 | 674.66 | 573.228 |
| Gross Profit
| 1,905.837 | 971.14 | 933.555 | 636.507 | 762.291 | 756.678 | 668.237 | 406.633 | 329.581 | 297.703 | 212.694 | 184.804 |
| Gross Profit Ratio
| 0.189 | 0.173 | 0.21 | 0.231 | 0.36 | 0.367 | 0.356 | 0.265 | 0.24 | 0.247 | 0.24 | 0.244 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 970.769 | 624.624 | 467.635 | 319.133 | 234.197 | 203.542 | 186.551 | 147.934 | 139.316 | 77.371 | 65.782 | 43.5 |
| Selling & Marketing Expenses
| 2.728 | 19.532 | 16.782 | 14.585 | 16.135 | 19.888 | 25.112 | 24.128 | 10.605 | 8.214 | 8.351 | 6.412 |
| SG&A
| 973.497 | 686.497 | 565.876 | 358.397 | 253.569 | 223.43 | 211.663 | 172.062 | 149.921 | 85.585 | 74.133 | 49.912 |
| Other Expenses
| 59.951 | 58.841 | 32.158 | 10.328 | 7.503 | 4.168 | 4.312 | 54.509 | 50.523 | 43.294 | 60.05 | 29.52 |
| Operating Expenses
| 943.052 | 776.305 | 727.087 | 283.851 | 270.067 | 228.776 | 161.528 | 1,897.407 | 130.176 | 30.084 | 45.134 | 49.762 |
| Operating Income
| 802.777 | 284.643 | 367.679 | 278.11 | 508.722 | 533.248 | 456.574 | 234.571 | 179.66 | 212.118 | 138.561 | 162.454 |
| Operating Income Ratio
| 0.079 | 0.051 | 0.083 | 0.101 | 0.24 | 0.259 | 0.243 | 0.153 | 0.131 | 0.176 | 0.156 | 0.214 |
| Total Other Income Expenses Net
| -309.856 | -42.23 | -97.204 | 140.075 | 32.577 | 55.695 | 102.933 | -1,687.052 | 68.308 | 104.641 | 4.448 | -15.176 |
| Income Before Tax
| 492.921 | 242.413 | 270.475 | 418.185 | 541.299 | 588.943 | 559.507 | -1,452.481 | 247.968 | 316.759 | 143.009 | 147.278 |
| Income Before Tax Ratio
| 0.049 | 0.043 | 0.061 | 0.152 | 0.256 | 0.286 | 0.298 | -0.948 | 0.181 | 0.263 | 0.161 | 0.194 |
| Income Tax Expense
| 165.031 | 83.071 | 155.389 | 97.864 | 140.665 | 149.387 | 129.812 | 47.331 | 75.554 | 77.23 | 46.865 | 36.544 |
| Net Income
| 257.68 | 138.974 | 417.915 | 310.131 | 390.865 | 430.898 | 421.034 | -1,506.964 | 167.045 | 230.051 | 89.992 | 101.088 |
| Net Income Ratio
| 0.025 | 0.025 | 0.094 | 0.113 | 0.185 | 0.209 | 0.224 | -0.983 | 0.122 | 0.191 | 0.101 | 0.133 |
| EPS
| 0.2 | 0.11 | 0.33 | 0.25 | 0.31 | 0.34 | 0.33 | -1.67 | 0.2 | 0.28 | 0.16 | 0.12 |
| EPS Diluted
| 0.2 | 0.11 | 0.33 | 0.25 | 0.31 | 0.34 | 0.33 | -1.67 | 0.2 | 0.28 | 0.16 | 0.12 |
| EBITDA
| 1,577.903 | 566.902 | 527.907 | 372.579 | 566.455 | 602.861 | 519.921 | 282.212 | 220.922 | 247.913 | 171.603 | 198.618 |
| EBITDA Ratio
| 0.156 | 0.101 | 0.119 | 0.135 | 0.268 | 0.293 | 0.277 | 0.184 | 0.161 | 0.206 | 0.193 | 0.262 |